skip to main content

Breast Cancer

Curing breast cancer but at what cost? Patients report heavy financial toll

A new study finds many breast cancer patients are concerned about the financial impact of their diagnosis and treatment, and that they feel their doctor’s offices are not helping with these concerns.

Integrative Therapies Guidelines Receive ASCO Endorsement

Many cancer patients use alternative medicine, including supplements, massage therapy, yoga, and acupuncture, while undergoing conventional cancer care. Such therapies are usually acceptable, but patients must discuss such therapies with their oncologist, because interactions may occur.

Tumor cells reprogram metabolic pathways in order to grow

Researchers at the U-M Rogel Cancer Center have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.

Research in mice finds a pill could improve breast cancer diagnosis

As many as one in three women treated for breast cancer undergo unnecessary procedures, which is why it's important to find new ways to diagnose the disease. Research in mice finds a special kind of pill could do a better job distinguishing between benign and aggressive tumors.

Half of Breast Cancer Patients Get Genetic Counseling

As new genes are linked to breast cancer occurring in families, and as genetic testing becomes more important in directing treatment for newly diagnosed patients, a substantial number of those at the highest risk are not getting tested.

Breast Cancer Survivor Climbs Mount Kilimanjaro

Kelly Luck discovered the importance of setting goals. Her goal: to climb Mout Kilimanjaro, gave her the motivation to get through her breast cancer treatment and emerge stronger than ever.

Jagsi discusses advances in radiation therapy with U.S. News

In an article in U.S. News and World Report, Reshma Jagsi, M.D., D.Phil., describes recent advances in radiation therapy to treat breast cancer.

Wall Street Journal: Chemotherapy 'falls out of favor'

The Wall Street Journal looks at efforts to improve how oncologists determine which patients need chemotherapy. What once was a crucial part of cancer treatment might now be best avoided for some patients at low risk. The article cites research from U-M Rogel Cancer Center member Steven Katz, M.D., MPH.

Breast Cancer Recurrence Risk Continues Years After Treatment

Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators published in the New England Journal of Medicine.

Pages